On October 15, 2019, CHLP presented a webinar entitled Is HIV Molecular Surveillance Worth The Risk? to review the scientific and public health implications of HIV molecular surveillance, and discuss how this technology fits in with ongoing HIV criminalization advocacy. Panelists include Jacob Schneider, CHLP Staff Attorney; Andrew Gans, MPH, HIV, STD and Hepatitis Section Manager, New Mexico Department of Health; and, Ronald Johnson, US People Living with HIV Caucus.
CHLP fights stigma and discrimination at the intersection of HIV, race, health status, disability, class, sexuality and gender identity and expression, with a focus on criminal and public health systems. As part of this work, we support movement building that amplifies the power of individuals and communities to mobilize for change rooted in racial, gender and economic justice. We do this through legal advocacy, high-impact policy initiatives, and creation of cross-issue partnerships, networks, and resources.